Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease

Allogeneic stem cell transplantation (allo-SCT) is the only curative option for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Azacitidine (AZA) has a good toxicity profile compared with intensive chemotherapy and can be considered a pre-transplant regimen in elderly patients and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Koichi, Ueno, Hironori, Okabe, Takashi, Kagoo, Toshiya, Boku, Saigen, Yano, Takahiro, Yokoyama, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477469/
https://www.ncbi.nlm.nih.gov/pubmed/28670436
http://dx.doi.org/10.4081/hr.2017.7114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477469/
https://www.ncbi.nlm.nih.gov/pubmed/28670436
http://dx.doi.org/10.4081/hr.2017.7114

Ejemplares similares